HT
ABCL icon

HAP Trading’s AbCellera Biologics ABCL Stock Holding History

HAP Trading’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 680
2024
Q2 		– Hold
0
– – – 655
2024
Q1 		– Hold
0
– – – 692
2023
Q4 		– Hold
0
– – – 937
2022
Q3 		– Hold
0
– – – 1700
2022
Q2 		– Hold
0
– – – 1897
2022
Q1 		– Hold
0
– – – 2162
2021
Q4 		– Hold
0
– – – 2489
2021
Q3 		– Sell
-11,474
Closed -$203K – 2391
2021
Q2 		$252K Buy
+11,474
New +$316K 0.02% 917

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return